- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Edwards Lifesciences Corp (EW)
Assess today's live Edwards Lifesciences Corp (EW) share price, performance and insights using our live NYSE: EW stock exchange data.
Analyse the historical data and Edwards Lifesciences Corp share price performance charts on this page. Our technical summary section provides analysis on Edwards Lifesciences share price buy/sell indicators using real-time data (or discuss the Edwards Lifesciences (EW) stock price today with other investors in the Edwards Lifesciences NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE EW share price (ISIN: US28176E1082) to enhance your trading decisions with our free investment tools and resources.
What Is the Edwards Lifesciences Corp Share Price Today?
The Edwards Lifesciences share price today is 83.66.
What Is the Stock Symbol for Edwards Lifesciences Corp
The stock symbol (or 'ticker') for Edwards Lifesciences Corp is "EW."
What Stock Exchange Does Edwards Lifesciences Corp Trade On?
Edwards Lifesciences Corp is listed and trades on the NYSE stock exchange.
Is Edwards Lifesciences Corp a Good Stock to Buy?
Determining whether Edwards Lifesciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Edwards Lifesciences Corp share price performance charts on this page. Our technical summary section provides analysis on Edwards Lifesciences share price buy/sell indicators using real-time data (or discuss the Edwards Lifesciences (EW) stock price today with other investors in the Edwards Lifesciences NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE EW share price (ISIN: US28176E1082) to enhance your trading decisions with our free investment tools and resources.
What Is the Edwards Lifesciences Corp Share Price Today?
The Edwards Lifesciences share price today is 83.66.
What Is the Stock Symbol for Edwards Lifesciences Corp
The stock symbol (or 'ticker') for Edwards Lifesciences Corp is "EW."
What Stock Exchange Does Edwards Lifesciences Corp Trade On?
Edwards Lifesciences Corp is listed and trades on the NYSE stock exchange.
Is Edwards Lifesciences Corp a Good Stock to Buy?
Determining whether Edwards Lifesciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
83.40
85.00
52 wk Range
65.94
87.89
EW is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
83.4085.00
52 wk Range
65.9487.89
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EW Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
97.02
Upside
+15.96%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Edwards Lifesciences Company Profile
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Edwards Lifesciences Corp SWOT Analysis
Market Leadership | Edwards Lifesciences dominates the TAVR market with robust growth, while expanding into promising TMTT segment with ambitious $2 billion sales target by 2030 |
Financial Health | Strong financials with 79.5% gross margins and 8.23% revenue growth. Analysts project double-digit EPS growth and margin expansion from 2026 onwards |
Regulatory Catalysts | Potential NCD changes could significantly boost TAVR adoption. FDA approval for asymptomatic aortic stenosis treatment may drive market expansion |
Analyst Perspectives | Price targets range from $80 to $90, reflecting confidence in growth potential. Analysts highlight TMTT and new market segments as key drivers |
Edwards Lifesciences Corp Earnings Call Summary for Q3/2025
- Edwards Lifesciences reported Q3 2025 adjusted EPS of $0.67 (13.56% above expectations) and revenue of $1.55 billion (up 12.6% YoY), despite a slight stock decline after hours.
- The company raised its full-year sales growth guidance to the high end of 9-10% range and adjusted EPS guidance to between $2.56 and $2.62, targeting 10% organic growth in 2026.
- Strong performance was driven by advancements in transcatheter aortic valve replacement (TAVR) and transcatheter mitral and tricuspid therapies (TMTT), with TMTT sales expected to reach $530-550 million.
- CEO Bernard Zovighian emphasized the company's leadership in the structural heart market, while CFO Scott Ullem highlighted R&D (18.1% of sales) as a strategic investment in top-line growth.
Last Updated: 30/10/2025, 22:34
Read Full TranscriptCompare EW to Peers and Sector
Metrics to compare | EW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEWPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.3x | 22.9x | −0.6x | |
PEG Ratio | −0.55 | 0.44 | 0.00 | |
Price/Book | 4.8x | 3.1x | 2.6x | |
Price / LTM Sales | 8.3x | 2.6x | 3.4x | |
Upside (Analyst Target) | 16.7% | 51.1% | 40.5% | |
Fair Value Upside | Unlock | 19.9% | 4.4% | Unlock |
Analyst Ratings
21 Buy
12 Hold
0 Sell
Ratings:
33 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 97.02
(+15.96% Upside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
0.67 / 0.59
Revenue / Forecast
1.55B / 1.50B
People Also Watch
FAQ
What Is the Edwards Lifesciences (EW) Share Price Today?
The live Edwards Lifesciences share price today is 83.66
What Stock Exchange Does Edwards Lifesciences (EW) Trade On?
Edwards Lifesciences is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Edwards Lifesciences?
The stock symbol (also called a 'ticker') for Edwards Lifesciences is "EW."
What Is the Current Edwards Lifesciences Market Cap?
As of today, Edwards Lifesciences market capitalisation is 48.69B.
What Is Edwards Lifesciences's (EW) Earnings Per Share (TTM)?
The Edwards Lifesciences EPS is currently 2.29 (Trailing Twelve Months).
When Is the Next Edwards Lifesciences Earnings Date?
Edwards Lifesciences's next earnings report will be released on 10 Feb 2026.
Is EW a Buy or Sell From a Technical Analyst Perspective?
Based on today's Edwards Lifesciences moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Edwards Lifesciences Stock Split?
Edwards Lifesciences has split 3 times. (See the EW stock split history page for full effective split date and price information.)
How Many Employees Does Edwards Lifesciences Have?
Edwards Lifesciences has 15800 employees.
What is the current trading status of Edwards Lifesciences (EW)?
As of 23 Jan 2026, Edwards Lifesciences (EW) is trading at a price of 83.66, with a previous close of 84.44. The stock has fluctuated within a day range of 83.40 to 85.00, while its 52-week range spans from 65.94 to 87.89.
What Is Edwards Lifesciences (EW) Price Target According to Analysts?
The average 12-month price target for Edwards Lifesciences is USD97.02, with a high estimate of USD110 and a low estimate of USD84. 21 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +15.96% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.